Resumo

MOYO-GWETE, Thandeka  e  MOORE, Penny L.. Leveraging on past investment in understanding the immunology of COVID-19 - the South African experience. S. Afr. j. sci. [online]. 2022, vol.118, n.5-6, pp.1-5. ISSN 1996-7489.  http://dx.doi.org/10.17159/sajs.2022/13171.

SIGNIFICANCE: The COVID-19 pandemic, and in particular the emergence of viral variants, resulted in an enormous global public health crisis. South African scientists, with a long history of studying viral evolution and antibody responses, were well positioned to pivot their research to focus on SARS-CoV-2. Using the expertise and infrastructure developed over decades for HIV vaccine research, South Africa took a leadership role in studying the antibody response elicited by SARS-CoV-2 infection and vaccination. We describe key scientific outcomes of those studies, and the drivers of a successful national response

Palavras-chave : HIV; SARS-CoV-2; vaccine research; immunology; virology.

        · texto em Inglês     · Inglês ( pdf )